Capital Region Doctors Advance Inflammation Research in Statewide Competition
Capital Region doctors Dr. Kate MacNamara and Dr. Rachel Grazda are advancing their research on chronic inflammation through their company, Resolvia Biosciences. They are finalists in a statewide competition and are competing in Buffalo.
Albany Schenectady Troy, NY, October 20, 2026 —
Capital Region doctors Dr. Kate MacNamara and Dr. Rachel Grazda are advancing research on chronic inflammation through their company, Resolvia Biosciences. The two doctors are finalists in a statewide competition and are competing in Buffalo.
The available information does not identify the competition, its organizers, the number of finalists, or the criteria used to select participants. It also does not say when the competition is taking place or describe what the finalists are required to do in Buffalo. No outcome has been provided.
The summary identifies chronic inflammation as the focus of MacNamara and Grazda’s research, but it does not provide details about the research itself, its stage of development, or any findings. It also does not explain how Resolvia Biosciences is involved in the work beyond describing it as the doctors’ company.
Further details about the company and the doctors’ roles were not provided. The information does not state whether the research is connected to a particular treatment, product, or clinical study, and it does not include comments from either doctor or from competition organizers.
For now, the reported development is that MacNamara and Grazda have reached finalist status in a statewide competition and are competing in Buffalo while advancing their chronic-inflammation research through Resolvia Biosciences. The competition’s name, schedule, judging process, and eventual results remain unspecified in the information available.
Story summarized from the original created by Jolie Santiago on wnyt.com, see more information here.
